{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T22:49:37Z","timestamp":1749682177015,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:00:00Z","timestamp":1714780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:00:00Z","timestamp":1714780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s10549-024-07337-3","type":"journal-article","created":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T11:01:33Z","timestamp":1714820493000},"page":"519-526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Disparities in PI3K\/mTOR inhibitor use, toxicities, and outcomes among patients with metastatic breast cancer"],"prefix":"10.1007","volume":"206","author":[{"given":"Claire","family":"Sathe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa K.","family":"Accordino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"DeStephano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansi","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn L.","family":"Hershman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,4]]},"reference":[{"issue":"6","key":"7337_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3322\/caac.21754","volume":"72","author":"AN Giaquinto","year":"2022","unstructured":"Giaquinto AN, Sung H, Miller KD et al (2022) Breast cancer statistics. CA Cancer J Clin 72(6):524\u2013541. https:\/\/doi.org\/10.3322\/caac.21754","journal-title":"CA Cancer J Clin"},{"key":"7337_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/107497","volume":"2011","author":"GK Singh","year":"2011","unstructured":"Singh GK, Williams SD, Siahpush M, Mulhollen A (2011) Socioeconomic, rural\u2013urban, and racial inequalities in US cancer mortality: Part I\u2014all cancers and lung cancer and Part II\u2014colorectal, prostate, breast, and cervical cancers. J Cancer Epidemiol 2011:107497. https:\/\/doi.org\/10.1155\/2011\/107497","journal-title":"J Cancer Epidemiol"},{"issue":"17","key":"7337_CR3","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1200\/JCO.2015.65.8716","volume":"34","author":"K Reeder-Hayes","year":"2016","unstructured":"Reeder-Hayes K, Peacock Hinton S, Meng K, Carey LA, Dusetzina SB (2016) Disparities in use of human epidermal growth hormone receptor 2-targeted therapy for early-stage breast cancer. J Clin Oncol 34(17):2003\u20132009. https:\/\/doi.org\/10.1200\/JCO.2015.65.8716","journal-title":"J Clin Oncol"},{"issue":"1","key":"7337_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-017-4490-3","volume":"167","author":"MS Dreyer","year":"2018","unstructured":"Dreyer MS, Nattinger AB, McGinley EL, Pezzin LE (2018) Socioeconomic status and breast cancer treatment. Breast Cancer Res Treat 167(1):1\u20138. https:\/\/doi.org\/10.1007\/s10549-017-4490-3","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"7337_CR5","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1200\/JCO.2011.36.8399","volume":"30","author":"XC Wu","year":"2012","unstructured":"Wu XC, Lund MJ, Kimmick GG et al (2012) Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers. J Clin Oncol 30(2):142\u2013150. https:\/\/doi.org\/10.1200\/JCO.2011.36.8399","journal-title":"J Clin Oncol"},{"issue":"1","key":"7337_CR6","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12916-020-01753-0","volume":"18","author":"RP Norris","year":"2020","unstructured":"Norris RP, Dew R, Sharp L et al (2020) Are there socio-economic inequalities in utilization of predictive biomarker tests and biological and precision therapies for cancer? A systematic review and meta-analysis. BMC Med 18(1):282. https:\/\/doi.org\/10.1186\/s12916-020-01753-0","journal-title":"BMC Med"},{"issue":"20","key":"7337_CR7","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1056\/NEJMoa1813904","volume":"380","author":"F Andre","year":"2019","unstructured":"Andre F, Ciruelos E, Rubovszky G et al (2019) Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer. N Engl J Med 380(20):1929\u20131940. https:\/\/doi.org\/10.1056\/NEJMoa1813904","journal-title":"N Engl J Med"},{"issue":"6","key":"7337_CR8","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1056\/NEJMoa1109653","volume":"366","author":"J Baselga","year":"2012","unstructured":"Baselga J, Campone M, Piccart M et al (2012) Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. N Engl J Med 366(6):520\u2013529. https:\/\/doi.org\/10.1056\/NEJMoa1109653","journal-title":"N Engl J Med"},{"issue":"1","key":"7337_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10549-022-06701-5","volume":"196","author":"KD Whitaker","year":"2022","unstructured":"Whitaker KD, Wang X, Ascha M et al (2022) Racial inequities in second-line treatment and overall survival among patients with metastatic breast cancer. Breast Cancer Res Treat 196(1):163\u2013173. https:\/\/doi.org\/10.1007\/s10549-022-06701-5","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"7337_CR10","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.1002\/cam4.1749","volume":"7","author":"Y Lou","year":"2018","unstructured":"Lou Y, Dholaria B, Soyano A et al (2018) Survival trends among non-small-cell lung cancer patients over a decade: impact of initial therapy at academic centers. Cancer Med 7(10):4932\u20134942. https:\/\/doi.org\/10.1002\/cam4.1749","journal-title":"Cancer Med"},{"issue":"6","key":"7337_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.19535","volume":"5","author":"T Ermer","year":"2022","unstructured":"Ermer T, Canavan ME, Maduka RC et al (2022) Association between Food and Drug Administration approval and disparities in immunotherapy use among patients with cancer in the US. JAMA Netw Open 5(6):e2219535. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.19535","journal-title":"JAMA Netw Open"},{"issue":"5","key":"7337_CR12","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1158\/1055-9965.EPI-18-0917","volume":"28","author":"LL Palazzo","year":"2019","unstructured":"Palazzo LL, Sheehan DF, Tramontano AC, Kong CY (2019) Disparities and trends in genetic testing and erlotinib treatment among metastatic non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 28(5):926\u2013934. https:\/\/doi.org\/10.1158\/1055-9965.EPI-18-0917","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"7337_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.0573","volume":"5","author":"N Goel","year":"2022","unstructured":"Goel N, Kim DY, Guo JA, Zhao D, Mahal BA, Alshalalfa M (2022) Racial differences in genomic profiles of breast cancer. JAMA Netw Open 5(3):e220573. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.0573","journal-title":"JAMA Netw Open"},{"issue":"24","key":"7337_CR14","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1001\/jama.2017.19546","volume":"318","author":"MP Bancks","year":"2017","unstructured":"Bancks MP, Kershaw K, Carson AP, Gordon-Larsen P, Schreiner PJ, Carnethon MR (2017) Association of modifiable risk factors in young adulthood with racial disparity in incident Type 2 diabetes during middle adulthood. JAMA 318(24):2457\u20132465. https:\/\/doi.org\/10.1001\/jama.2017.19546","journal-title":"JAMA"},{"issue":"1","key":"7337_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10549-020-05756-6","volume":"183","author":"MK Accordino","year":"2020","unstructured":"Accordino MK, Wright JD, Buono D et al (2020) Incidence and predictors of diabetes mellitus after a diagnosis of early-stage breast cancer in the elderly using real-world data. Breast Cancer Res Treat 183(1):201\u2013211. https:\/\/doi.org\/10.1007\/s10549-020-05756-6","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07337-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-024-07337-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07337-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T10:36:26Z","timestamp":1719398186000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-024-07337-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,4]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["7337"],"URL":"https:\/\/doi.org\/10.1007\/s10549-024-07337-3","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2024,5,4]]},"assertion":[{"value":"8 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is an observational study of de-identified patient data. All necessary approvals and\/or exemptions have been obtained from the CUIMC Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}